HCV core antigen (Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag)) antibody and antigen (Recombinant protein)
Diagnostic antibodies (anti-HCV core antigen, anti-Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag)) and antigens (recombinant protein) for Infectious disease Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-IVD-P007-Tg001-Ag01 | Recombinant human hepatitis C virus (HCV) Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) Protein | 3090 |
GMP-IVD-P007-Tg001-Ab01 | Anti-human hepatitis C virus (HCV) Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) mouse monoclonal antibody (mAb) | 1953 |
GMP-IVD-P007-Tg001-Ab02 | Anti-human hepatitis C virus (HCV) Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) mouse monoclonal antibody (mAb) | 1953 |
GMP-IVD-P007-Tg001-Ab03 | Anti-human hepatitis C virus (HCV) Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) human monoclonal antibody (mAb) | 1953 |
GMP-IVD-P007-Tg001-Ab04 | Anti-human hepatitis C virus (HCV) Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-IVD-P007-Tg001-Ag01 |
Product Name | Recombinant human hepatitis C virus (HCV) Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) Protein |
Pathogen | hepatitis C virus |
Target/Biomarker | Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | HCV core antigen (Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) level test of Infectious disease (Hepatitis C) and related syndrome evaluation. |
Tag | His |
Products description | Recombinant human hepatitis C virus (HCV) Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) Protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-IVD-P007-Tg001-Ab01, GMP-IVD-P007-Tg001-Ab02 |
Product Name | Anti-human hepatitis C virus (HCV) Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) mouse monoclonal antibody (mAb) |
Pathogen | hepatitis C virus |
Target/Biomarker | Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | HCV core antigen (Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) level test of Infectious disease (Hepatitis C) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human hepatitis C virus (HCV) Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) mouse monoclonal antibody (mAb) was expressed in CHO - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-IVD-P007-Tg001-Ab03, GMP-IVD-P007-Tg001-Ab04 |
Product Name | Anti-human hepatitis C virus (HCV) Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) human monoclonal antibody (mAb) |
Pathogen | hepatitis C virus |
Target/Biomarker | Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | HCV core antigen (Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) level test of Infectious disease (Hepatitis C) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human hepatitis C virus (HCV) Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) human monoclonal antibody (mAb) was expressed in CHO - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Hepatitis C is an infectious disease caused by the hepatitis C virus (HCV) that primarily affects the liver. During the initial infection people often have mild or no symptoms. Occasionally a fever, dark urine, abdominal pain, and yellow tinged skin occurs. It often leads to liver disease and occasionally cirrhosis. In some cases, those with cirrhosis will develop serious complications such as liver failure, liver cancer, or dilated blood vessels in the esophagus and stomach.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments